Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent.

Current drug targets - 1 Sept 2007

Cale Jacqueline M, Lawrence Daniel A

Abstract excerpt

Plasminogen activator inhibitor-1 (PAI-1) is the primary inhibitor of tissue-type and urokinase-type plasminogen activators (tPA and uPA, respectively). PAI-1 also interacts with non-proteinase targets such as vitronectin, heparin, and several endocytic receptors of the low-density lipoprotein-receptor family, including the low-density lipoprotein-receptor related protein (LRP) and the very low-density...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Plasminogen Activator Inhibitor 1
Share to Protein Structure, Secondary

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Serine Proteinase Inhibitors

Share to Structure-Activity Relationship

Share to Transcription, Genetic

Source

Identifiers

PMID: 17896949
DOI: 10.2174/138945007781662337

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent.PMID 17896949Read ↗

Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted SerpinSemantic proximity Read ↗

The structural basis for the pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of potential PAI-1 inhibitorsSemantic proximity Read ↗

Historical analysis of PAI-1 from its discovery to its potential role in cell motility and diseaseSemantic proximity Read ↗

Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484Semantic proximity Read ↗

Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumorsSemantic proximity Read ↗

The Molecular Basis for Anti-Proteolytic and Non-Proteolytic Functions of Plasminogen Activator Inhibitor Type-1: Roles of the Reactive Centre Loop, the Shutter Region, the Flexible Joint Region and the Small Serpin FragmentSemantic proximity Read ↗

The story of the serpin plasminogen activator inhibitor 1: is there any need for another mutant?Semantic proximity Read ↗

The status of PAI-1 as a risk factor for arterial and thrombotic disease: A reviewSemantic proximity Read ↗

The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding.Semantic proximity Read ↗

Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure.Semantic proximity Read ↗

Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1Semantic proximity Read ↗

Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.